carbostyril has been researched along with Learning Disabilities in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brady, AE; Bridges, TM; Christian, EP; Conn, PJ; Davis, AA; Doherty, JJ; Jadhav, SB; Jones, PJ; Kennedy, JP; Lah, JJ; Levey, AI; Lindsley, CW; Menon, UN; Nicolle, MM; Quirk, MC; Shirey, JK; Snyder, DH; Watson, ML; Xiang, Z | 1 |
Stern, AP; Trieu, ML | 1 |
2 other study(ies) available for carbostyril and Learning Disabilities
Article | Year |
---|---|
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
Topics: Animals; Carboxylic Acids; CHO Cells; Cholinergic Agents; Cricetinae; Cricetulus; Female; Humans; In Vitro Techniques; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neurons; Prefrontal Cortex; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Reversal Learning | 2009 |
A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Blood Glucose; Diabetes Mellitus, Type 1; Hospitalization; Humans; Hyperglycemia; Language Disorders; Learning Disabilities; Male; Piperazines; Quinolones; Risperidone | 2012 |